Clinical-stage Biopharmaceutical Company Granted Major European Patent
OKYO Pharma Granted European Patent Covering OK-101 Chemerin Analogs and Their Method of Use.
Disclaimer: This article is for informational purposes only and should not be construed as investment or medical advice. Always consult with a qualified professional before making any business or healthcare decisions.
Real-time information is available daily at https://stockregion.net